← All companies

NONO

Novo Nordisk A/S

NONOF NYSE Pharmaceutical Preparations EDGAR ↗

$45.83

-0.18 -0.39%

Key statistics

from XBRL data in SEC filings

Market cap

—

Revenue (TTM)

—

Net income (TTM)

—

EPS (TTM)

—

P/E ratio

—

Dividend yield

—

Free cash flow

—

Cash

—

Total assets

—

Gross margin

—

52-week range

$34.00 – $64.75

Recent SEC filings

40 most recent

Annual, quarterly & current reports

6-K FORM 6-K Jul 31, 2026 6-K FORM 6-K Jul 27, 2026 6-K FORM 6-K Jul 21, 2026 6-K FORM 6-K Jul 13, 2026 6-K FORM 6-K Jul 6, 2026 6-K FORM 6-K Jun 29, 2026 6-K FORM 6-K Jun 24, 2026 6-K FORM 6-K Jun 15, 2026 6-K FORM 6-K Jun 8, 2026 6-K FORM 6-K Jun 1, 2026 6-K FORM 6-K May 27, 2026 6-K FORM 6-K May 22, 2026 6-K FORM 6-K May 22, 2026 6-K FORM 6-K May 18, 2026 6-K FORM 6-K May 13, 2026 6-K May 6, 2026 6-K FORM 6-K May 5, 2026 6-K FORM 6-K Apr 27, 2026 6-K FORM 6-K Apr 20, 2026 6-K FORM 6-K Apr 20, 2026 6-K FORM 6-K Apr 13, 2026 6-K FORM 6-K Apr 7, 2026 6-K FORM 6-K Mar 30, 2026 6-K FORM 6-K Mar 27, 2026 6-K FORM 6-K Mar 27, 2026 6-K FORM 6-K Mar 26, 2026 6-K FORM 6-K Mar 23, 2026 6-K FORM 6-K Mar 20, 2026 6-K FORM 6-K Mar 17, 2026 6-K FORM 6-K Mar 9, 2026 6-K FORM 6-K Mar 2, 2026 6-K FORM 6-K Mar 2, 2026 6-K FORM 6-K Feb 23, 2026 6-K FORM 6-K Feb 23, 2026 6-K FORM 6-K Feb 20, 2026 6-K FORM 6-K Feb 17, 2026 6-K FORM 6-K Feb 11, 2026 6-K FORM 6-K Feb 10, 2026 6-K FORM 6-K Feb 9, 2026 6-K FORM 6-K Feb 5, 2026